Objective: To estimate the accuracy of a new assay to determine the fetal RHD status using circulating cell-free DNA.
Methods: This was a prospective, observational study. Maternal blood samples were collected in each trimester of pregnancy in 520 nonalloimmunized RhD-negative patients.